Stock listing
TSXV:TELO Telo Genomics Corp. Stock
Home listing (TSXV) of Telo Genomics Corp.
Follow Telo Genomics Corp. into a list and get an email when it puts out news.
Share price · TSXV:TELO
$0.04 CAD -0.00 (-11.1%)
Close on Nov 20, 2026
- Day range
- $0.04 – $0.04 CADNov 20, 2026
- Volume
- 115,500 sharesNov 20, 2026
- Market cap
- $4.02M CADAt the close on Nov 20, 2026 · price × 100.4M shares outstanding
- 52-week range
- $0.025 – $0.105 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2,732 CADMedian day 5,000 shares · 27 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:TELO · Home | $0.04 CAD | -0.005 (-11.1%) | 115,500 | $0.04 | $0.04 | $0.04 | $0.045 | Close on Nov 20, 2026 |
| OTC:TDSGF | $0.025 USD | -0.005 (-15.7%) | 200 | $0.025 | $0.025 | $0.025 | $0.030 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TSXV:TELO · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.04 | -0.005 | -11.1% | $0.04 | $0.04 | $0.04 | 115,500 | |
| $0.045 | -0.005 | -10.0% | $0.05 | $0.055 | $0.045 | 112,330 | |
| $0.05 | +0.005 | +11.1% | $0.05 | $0.05 | $0.05 | 19,000 | |
| $0.045 | 0.00 | 0.0% | $0.05 | $0.05 | $0.045 | 41,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | -0.005 | -10.0% | $0.05 | $0.05 | $0.045 | 6,673 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 7,722 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 10,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 5,000 | |
| $0.05 | -0.005 | -9.1% | $0.05 | $0.05 | $0.05 | 6,000 | |
| $0.055 | 0.00 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | -0.015 | -21.4% | $0.06 | $0.06 | $0.055 | 8,000 | |
| $0.07 | +0.01 | +16.7% | $0.07 | $0.07 | $0.07 | 1,000 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 0 | |
| $0.06 | -0.01 | -14.3% | $0.07 | $0.07 | $0.06 | 101,022 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.075 | $0.08 | $0.07 | 258,354 | |
| $0.07 | +0.02 | +40.0% | $0.06 | $0.075 | $0.055 | 185,463 | |
| $0.05 | -0.005 | -9.1% | $0.055 | $0.055 | $0.05 | 36,000 | |
| $0.055 | +0.005 | +10.0% | $0.065 | $0.105 | $0.045 | 153,000 | |
| $0.05 | -0.005 | -9.1% | $0.055 | $0.06 | $0.05 | 54,100 | |
| $0.055 | -0.005 | -8.3% | $0.055 | $0.055 | $0.055 | 12,158 | |
| $0.06 | +0.01 | +20.0% | $0.05 | $0.065 | $0.05 | 300,352 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 5,000 | |
| $0.05 | +0.015 | +42.9% | $0.035 | $0.05 | $0.035 | 218,000 | |
| $0.035 | 0.00 | 0.0% | $0.035 | $0.035 | $0.025 | 425,500 | |
| $0.035 | 0.00 | 0.0% | $0.035 | $0.035 | $0.035 | 50,000 | |
| $0.035 | 0.00 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.00 | 0.0% | $0.04 | $0.04 | $0.035 | 11,000 | |
| $0.035 | -0.005 | -12.5% | $0.04 | $0.04 | $0.035 | 51,400 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 3,550 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.05 | $0.035 | 184,000 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | -0.005 | -11.1% | $0.04 | $0.04 | $0.04 | 145,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.05 | $0.045 | 463,026 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | +0.005 | +12.5% | $0.045 | $0.045 | $0.045 | 40,000 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | +0.005 | +14.3% | $0.04 | $0.04 | $0.04 | 102,000 | |
| $0.035 | -0.005 | -12.5% | $0.035 | $0.035 | $0.035 | 39,000 | |
| $0.04 | -0.005 | -11.1% | $0.045 | $0.045 | $0.04 | 133,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 3,015 | |
| $0.045 | -0.005 | -10.0% | $0.045 | $0.045 | $0.04 | 108,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 2,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | +0.005 | +11.1% | $0.04 | $0.05 | $0.04 | 193,000 |
Splits
2 splits since 2016 · TSXV:TELO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-5 | Consolidation | |
| 1-for-2 | Consolidation |
- Ticker
- TSXV:TELO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Nov 20, 2026
Telo Genomics Corp. Announces Non-Brokered Private Placement of Secured Convertible Debentures
Latest deck · December 2025
Investor Presentation (December 2025)
Investor deck · 19 slides
Latest news
Telo Genomics Corp. Announces Non-Brokered Private Placement of Secured Convertible Debentures
Nov 20, 2026
Closed $0.04 (-11.1%) on Nov 20, 2026
Telo Genomics Announces Term Sheet Providing an Option for Exclusive Worldwide License to AI Technology for Automated Detection of Rare Malignant Cells
Nov 18, 2026
Closed $0.045 (-10.0%) on Nov 18, 2026
Telo Genomics Announces $250,000 Term Loan Facility
Nov 6, 2026
Closed $0.045 (0.0%) on Nov 9, 2026
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
Oct 29, 2026
Closed $0.05 (0.0%) on Oct 29, 2026
Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing
Sep 29, 2026
Closed $0.035 (0.0%) on Sep 29, 2026
Telo Genomics Announces Clinical Research Results Evidencing Utility of Its Telomere Analysis Platform in Predicting Multiple Myeloma Relapse
Sep 15, 2026
Closed $0.045 (0.0%) on Sep 15, 2026
Telo Genomics Grants Stock Options
Aug 4, 2026
Closed $0.045 (0.0%) on Aug 4, 2026
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Jul 16, 2026
Closed $0.045 (0.0%) on Jul 16, 2026
Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma
Jul 9, 2026
Closed $0.045 (+12.5%) on Jul 9, 2026
Telo Genomics Announces Termination of Investor Relations Agreement
Jun 26, 2026
Closed $0.04 (0.0%) on Jun 29, 2026
Financings
Secured convertible debentures
Nov 20, 2026 · US$698,470
Announced: up to C$1M · C$0.05 · Warrants at C$0.08 for 12 months
Use of proceeds: Lab trials and general working capital
Non-transferable secured convertible debentures
Feb 27, 2026 · US$614,125
Tranche closed: C$840,000 raised · C$0.05 · Warrants at C$0.08 for 12 months · free to trade Jun 18, 2026
Use of proceeds: Working capital and general corporate purposes
Announced Jan 19, 2026 · Tranche closed Feb 18, 2026 · Made bigger Feb 27, 2026
Private placement of units
Dec 23, 2024 · US$1.77M
Closed: C$2.55M raised · C$0.1 a unit · Warrants at C$0.15 for 36 months · free to trade Apr 24, 2025
Insiders: A director of the Company acquired 150,000 Units
Use of proceeds: Partnering multiple myeloma prognostics, SMART program for TeloViewSMM, MRD validation, prostate cancer test development, working capital
Decks
Investor Presentation (December 2025)
Investor deck · 19 slides · December 2025
Telo Genomics Corp. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 21 in the last 12 months · 95 in all · newest Nov 20, 2026 · oldest 2016
- Decks
- 1 deck · latest December 2025
Where Telo Genomics Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:TELO · Home listing · This page | TSXV | Canada | CAD |
| OTC:TDSGF | OTC | United States | USD |
| LS Exchange:A2PV0Q | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PV0Q | Lang & Schwarz | Germany | EUR |
| Munich:3D0A | Munich | Germany | EUR |
| Cboe Canada:TELO | Cboe Canada | Canada | CAD |
| gettex:3D0A | gettex | Germany | EUR |
| Frankfurt:3D0A | Frankfurt | Germany | EUR |
| Stuttgart:3D0A | Stuttgart | Germany | EUR |
| Tradegate:3D0A | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Telo Genomics Corp.